Researchers have developed an artificial intelligence model that enhances the ability to predict which cancer patients will develop resistance to drug treatments. The AI system could help oncologists identify patients at higher risk earlier and adjust treatment strategies accordingly.
Why it matters: Better prediction of drug resistance could transform cancer treatment planning and improve patient outcomes by enabling more personalized therapeutic approaches.